Q & A
Ask a question
There are no questions yet
🇬🇧 Michael (UK) — ordered Gefticip 250mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Gefticip 250mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🇬🇧 Michael (UK) — ordered Gefticip 250mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Gefticip 250mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🩺 Anti Cancer
Sale!
Gefticip 250mg Tablet
Manufactured by / Trademark: Cipla
81 viewing now
13 enquiries / 48 hrs
8 shipped / week
Our Price
$3,404
Global Retail
$5,491
Save $2,087 (38% off)
In Stock — Ships within 48 hrs
📦 Bulk discounts available — enquire for volume pricing
🔥 4 people ordered in the last 24 hours · Only 3 units remaining
Genuine Stock
Export Docs
Discreet Pack
Cold-Chain
🚚 Estimated Delivery to Your Country
🇬🇧🇩🇪🇫🇷
Europe
7–10 days
Express courier
🇺🇸🇨🇦🇦🇺
US / CA / AU
10–14 days
EMS / courier
🇦🇪🇸🇦🇯🇵
Middle East / Asia
5–8 days
Express courier
Trustpilot
★★★★★
Excellent
4.6 / 5
21 verified reviews
🔒 Secure Payment Options
SSL encrypted · All transactions are private & secure
Gefticip 250mg Tablet (Gefitinib) is a targeted therapy medication used to treat non-small cell lung cancer (NSCLC). It works by inhibiting the epidermal growth factor receptor (EGFR), effectively slowing down the growth and spread of cancer cells.
Gefticip 250mg Tablet contains Gefitinib, a selective tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). By blocking the action of EGFR, Gefitinib disrupts cancer cell proliferation, making it an essential part of targeted cancer therapy.
Key Features:
- Contains Gefitinib, a potent targeted therapy medication
- Primarily used for treating non-small cell lung cancer (NSCLC)
- Inhibits EGFR activity to slow down the growth of cancer cells
- Convenient oral dosage form for ease of use
- Often prescribed as part of a comprehensive cancer treatment plan
Frequently Ordered Together
View all →
Reviews
There are no reviews yet